Since it is generally believed that FAs are necessary for cancer cells to build up membranes and enhance proliferation/growth, one might argue that ATGL-released FAs may contribute to a proliferative phenotype, rather than an anti-proliferative one. Here, PNPLA2 is linked to cancer.